Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
7,421 total articles
Nvidia has committed to supplying 1 million graphics processing units to Amazon Web Services between 2026 and 2027, with deliveries beginning this year and continuing through 2027. The arrangement covers a broad slate of Nvidia chips, newly licensed Groq processors, and networking hardware, and aligns with Nvidia CEO Jensen Huang's projection of a …
Underwriters for MDA Space Ltd. have exercised their over-allotment option, acquiring 1,344,071 additional common shares at $30.50 each. The move yielded roughly $41 million in extra gross proceeds, lifting the total raised in the offering to about $341 million. The financing was managed by a syndicate led by J.P. Morgan and RBC Capital Markets, wi…
Jefferies upgraded SolarEdge to a Hold from underperform and lifted its price target to $49 from $30, citing renewed volatility in European energy markets as a potential tailwind for solar and storage demand. The firm raised its 2027 and 2028 revenue forecasts while leaving 2026 largely unchanged, but stopped short of a Buy because the stock alread…
Silgan Holdings has indicated interest in acquiring German medical packaging maker Gerresheimer and is working with advisers on a possible approach, though sources say there is no guarantee a bid will materialize. Gerresheimer's stock jumped after the news even as the company continues to face an expanding probe by Germany's financial regulator and…
Ultra-low-cost carriers (ULCCs) operate some of the most fuel-efficient aircraft in the U.S., a structural advantage amid rising jet fuel costs. However, the newer, higher-cost planes central to that efficiency create financial strain if passenger demand weakens, because idling or reducing utilization of recently acquired jets is more expensive tha…
Bernstein names three European pharmaceutical stocks as top buys, citing undervalued pipelines, potential earnings upgrades and catalysts that could trigger a re-rating. The brokerage’s price targets imply upside ranging from 36% to 53% from current levels, with AstraZeneca rated its top large-cap pick, GSK second among large caps, and Argenx the h…
Insider filings disclosed Thursday show a mix of concentrated insider buying in several names trading near lows alongside sizable sales executed by executives and affiliated investors in other companies. The most valuable reported purchase involved a group of Pale Fire Capital entities and related individuals acquiring more than $18 million of Phre…
Futures tied to Canada’s main stock index opened lower on Friday as investors continued to weigh elevated oil prices and fresh developments in the Iran war. The S&P/TSX composite closed at its lowest level since February on Thursday, dragged down by falling gold prices and risk-off positioning in miners, while gains in crude helped sustain energy s…
UBS has moved its recommendation on UK equities to neutral, arguing that while valuations are reasonable and earnings are set to grow, upside is constrained relative to global markets. The bank highlights current valuation metrics, earnings forecasts for 2026 and 2027, sector preferences and alternative FTSE 100 scenarios tied to global growth, com…
HSBC upgraded Arm to Buy from Reduce and lifted its price target to $205 from $90, saying the market has not fully priced in Arm’s pivot toward AI-driven server CPUs. The bank forecasts sharply higher industry CPU shipments in 2026-27, accelerating royalty income tied to adoption of Arm v9 and Neoverse Compute Subsystems, and identifies a possible …
U.S. equity futures opened lower as oil fluctuated and geopolitical developments in Iran kept investors on edge. In premarket action, FedEx jumped more than 9% after raising its full-year profit outlook and reporting stronger-than-expected fiscal third-quarter results tied to holiday demand, while Super Micro Computer slid sharply following crimina…
SkinBioTherapeutics Plc said it will not meet the AIM deadline to publish its half-year 2026 interim results after a board-ordered forensic review remains in progress. The Newcastle-based life sciences firm warned trading in its ordinary shares is likely to be suspended from April 1 pending conclusion of the investigation, a development that sent t…
Flowco Holdings Inc. (FLOC) saw its stock fall roughly 10% after affiliates of GEC Advisors LLC announced an underwritten public offering priced at $22.00 per share, below the previous close of $23.64. The selling stockholders are offering 7,800,000 Class A shares with an underwriters' option for 1,170,000 additional shares. Flowco will not sell ne…
Jefferies' retail tracking for the four weeks ending February 22 shows Western Europe food retail sales up 5.4% versus the prior four-week average of 6.6%, with on-the-ground volume gains limited to four of nine categories. Prices increased across the board, coffee and chocolate led price inflation, and private label share expanded in almost every …
UBS upgraded Polish energy group Orlen SA from sell to neutral and raised its 12-month price target to PLN120 from PLN100, citing higher oil and gas prices and wider refining margins driven by disruptions in the Middle East. The bank materially increased its price and earnings assumptions for 2026 and 2027, while flagging several downside risks inc…
U.S. stock futures opened under pressure after a volatile week for energy markets driven by strikes on major Middle Eastern energy infrastructure and retaliatory attacks tied to the war in Iran. Brent crude briefly spiked to about $119 a barrel before easing toward $107, while natural gas benchmarks also jumped as Qatar reported damage to a large e…
SAP SE Chief Executive Christian Klein said the defense sector has emerged as the company’s fastest-growing business line amid rising global military budgets. Klein told reporters there is strong demand for upgraded software and AI to help scale defense operations. The company currently derives roughly 10% of its revenue from defense work and is mi…
On March 20, Super Micro saw its stock fall sharply after U.S. prosecutors charged three people connected to the company with participating in an alleged plot to divert billions of dollars of U.S. AI technology to China. The company said it was not listed as a defendant, cooperated with investigators and has placed the employees on leave while seve…
UBS has retained an "Attractive" rating on global equities even as it flags heightened energy-related downside risks following disruptions to flows through the Strait of Hormuz. The bank expects de-escalation within weeks, projects 12% earnings growth for the MSCI AC World Index this year, and recommends diversified exposure to structural themes wh…
Prestige Consumer Healthcare will purchase the Breathe Right brand and related assets from Foundation Consumer Healthcare for $1.045 billion, a figure that falls to about $900 million after tax benefits. The acquisition, which is expected to close in the first half of 2027, brings a brand that generated roughly $200 million in revenue and $95 milli…
Oil prices remained high on Friday amid sustained fears that damage to energy infrastructure and attacks tied to the Iran conflict will restrict supplies for an extended period. Brent crude held near $108 a barrel after touching roughly $119 earlier in the week following strikes on Iranian and regional natural gas facilities. Damage to major produc…
Eris Lifesciences has released a generic version of semaglutide in India under the brand name Sundae, offering a 2 mg vial at 1,290 rupees per month (about $13.8). The company and its partner Natco Pharma are pricing the injectable well below established branded competitors, and Eris will introduce a pen device with multiple dosages in April.
Dell Technologies stock rose modestly while Super Micro Computer plunged after U.S. prosecutors charged a co-founder and two associates with diverting billions of dollars in Nvidia-powered servers to China in violation of export controls. The criminal indictment and ensuing market reaction raise reputational and control-related concerns for Super M…
UBS maintains an "Attractive" rating on U.S. equities, projecting the S&P 500 will climb to 7,300 by June and 7,700 by December 2026. The bank points to healthy corporate profit growth, anticipated Federal Reserve rate cuts, and value creation from AI adoption as key supports, while warning that prolonged disruptions to Persian Gulf energy flows co…
Rhythm Pharmaceuticals saw its stock rise after the FDA approved IMCIVREE (setmelanotide) to treat acquired hypothalamic obesity in patients aged 4 years and older, based on positive Phase 3 TRANSCEND trial results showing a statistically significant placebo-adjusted reduction in BMI. The drug will be available to U.S. patients immediately.
